The Conformable GORE® TAG® Thoracic Endoprosthesis is the leading option for the endovascular treatment of thoracic aneurysms, transections and all Type B dissections.

As a proven endovascular treatment for the thoracic aorta, the Conformable GORE® TAG® Thoracic Endoprosthesis provides physicians with many benefits, including:

  • Optimized Conformability: Designed to treat compromised aortas and provide optimal outcomes in a wide range of pathologies 
  • Patient Fit: Only device engineered to perform in 6 – 33% oversizing conditions allowing physicians to choose radial force to fit patient anatomy
  • Proven Results: Strong clinical data and more than 18 years of experience in thoracic endovascular aortic repair (TEVAR); more than 94,000 GORE® TAG® Thoracic Devices have been distributed worldwide1

The time-tested Conformable GORE® TAG® Thoracic Endoprosthesis provides less-invasive endovascular treatment for diseases of the descending thoracic aorta, including aneurysms, transections, and all Type B dissections. Our highly respected and trusted device is known for its performance and durability. The GORE® TAG® Thoracic Endoprosthesis is the most studied thoracic endograft available.2 Off-the-shelf tapered devices are available for the tapered anatomies of young trauma patients.

  1. Data on file.
  2. With the first clinical implant occurring in 1998, the GORE® TAG® Device has been studied in ten FDA-approved clinical studies, one European clinical trial (ADSORB) and one worldwide registry (GREAT).